Ignite Creation Date:
2025-12-25 @ 3:19 AM
Ignite Modification Date:
2026-05-25 @ 11:06 AM
Study NCT ID:
NCT04454905
Status:
UNKNOWN
Last Update Posted:
2023-04-19
First Post:
2020-06-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Camrelizumab in Combination With Apatinib in Advanced ICC: A Single-arm Phase II Study
Sponsor:
Sun Yat-sen University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Intrahepatic Cholangiocarcinoma | View |
Keywords: